These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15734994)

  • 1. Effects of DNA methylation on galectin-3 expression in pituitary tumors.
    Ruebel KH; Jin L; Qian X; Scheithauer BW; Kovacs K; Nakamura N; Zhang H; Raz A; Lloyd RV
    Cancer Res; 2005 Feb; 65(4):1136-40. PubMed ID: 15734994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of galectin-3 in pituitary tumors.
    Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
    Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
    Simpson DJ; Hibberts NA; McNicol AM; Clayton RN; Farrell WE
    Cancer Res; 2000 Mar; 60(5):1211-6. PubMed ID: 10728677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
    Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
    Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation.
    Bahar A; Bicknell JE; Simpson DJ; Clayton RN; Farrell WE
    Oncogene; 2004 Jan; 23(4):936-44. PubMed ID: 14647444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and consequences of galectin-3 expression in pituitary tumors.
    Righi A; Jin L; Zhang S; Stilling G; Scheithauer BW; Kovacs K; Lloyd RV
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):8-14. PubMed ID: 20451577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation.
    Ahmed H; Banerjee PP; Vasta GR
    Biochem Biophys Res Commun; 2007 Jun; 358(1):241-6. PubMed ID: 17481580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements.
    Kondoh N; Hada A; Ryo A; Shuda M; Arai M; Matsubara O; Kimura F; Wakatsuki T; Yamamoto M
    Int J Oncol; 2003 Dec; 23(6):1575-83. PubMed ID: 14612929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing.
    Xing M; Usadel H; Cohen Y; Tokumaru Y; Guo Z; Westra WB; Tong BC; Tallini G; Udelsman R; Califano JA; Ladenson PW; Sidransky D
    Cancer Res; 2003 May; 63(9):2316-21. PubMed ID: 12727856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
    Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
    Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
    Song Y; Zhang C
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.
    Bello MJ; De Campos JM; Isla A; Casartelli C; Rey JA
    Oncol Rep; 2006 Feb; 15(2):443-8. PubMed ID: 16391867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of galectin-3 expression in mucinous colorectal carcinomas is associated with 5'CpG island methylation in Tunisian patients.
    Mahmoud LK; Arfaoui A; Khiari M; Chaar I; El Amine O; Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):258-65. PubMed ID: 21494181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
    Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
    Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 Expression in Functioning and Silent ACTH-Producing Adenomas.
    Jin L; Riss D; Ruebel K; Kajita S; Scheithauer BW; Horvath E; Kovacs K; Lloyd RV
    Endocr Pathol; 2005; 16(2):107-14. PubMed ID: 16199895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
    Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
    Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.